Catalyst Wire Dossier Catalyst Wire Dossier

Glucophage Extended Release Reduced Mass 500 mg

metformin extended-release reduced mass · Merck Healthcare KGaA (affiliate of Merck KGaA, Darmstadt, Germany)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Glucophage Extended Release Reduced Mass 500 mg, covering 2023-12-29 to 2023-12-29. Get the full timeline:

Most recent: Clinical Trial Update: GXR RM (Glucophage® Extended Release Reduced Mass) 500 Milligram (mg) Korea Bioequivalence (BE) Study [Phase 1]

See pricing